AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45
EFFECT OF MECHANICAL LOADING ON VASCULAR ALPHA(1D)-ADRENERGIC AND ALPHA(1B)-ADRENERGIC RECEPTOR EXPRESSION
Authors: CLEMENTS ML BANES AJ FABER JE
Citation: Ml. Clements et al., EFFECT OF MECHANICAL LOADING ON VASCULAR ALPHA(1D)-ADRENERGIC AND ALPHA(1B)-ADRENERGIC RECEPTOR EXPRESSION, Hypertension, 29(5), 1997, pp. 1156-1164
MECHANICAL LOAD OPPOSES ANGIOTENSIN-MEDIATED DECREASE IN VASCULAR ALPHA(1)-ADRENOCEPTORS
Authors: CLEMENTS ML FABER JE
Citation: Ml. Clements et Je. Faber, MECHANICAL LOAD OPPOSES ANGIOTENSIN-MEDIATED DECREASE IN VASCULAR ALPHA(1)-ADRENOCEPTORS, Hypertension, 29(5), 1997, pp. 1165-1172
CLADE B-BASED HIV-1 VACCINES ELICIT CROSS-CLADE CYTOTOXIC T-LYMPHOCYTE REACTIVITIES IN UNINFECTED VOLUNTEERS
Authors: FERRARI G HUMPHREY W MCELRATH MJ EXCLER JL DULIEGE AM CLEMENTS ML COREY LC BOLOGNESI DP WEINHOLD KJ
Citation: G. Ferrari et al., CLADE B-BASED HIV-1 VACCINES ELICIT CROSS-CLADE CYTOTOXIC T-LYMPHOCYTE REACTIVITIES IN UNINFECTED VOLUNTEERS, Proceedings of the National Academy of Sciences of the United Statesof America, 94(4), 1997, pp. 1396-1401
NEUTRALIZATION OF A CLADE-B PRIMARY ISOLATE BY SERA FROM HUMAN-IMMUNODEFICIENCY-VIRUS-UNINFECTED RECIPIENTS OF CANDIDATE AIDS VACCINES
Authors: ZOLLAPAZNER S ALVING C BELSHE R BERMAN P BURDA S CHIGURUPATI P CLEMENTS ML DULIEGE AM EXCLER JL HIOE C KAHN J MCELRATH MJ SHARPE S SINANGIL F STEIMER K WALKER MC WASSEF N XU S
Citation: S. Zollapazner et al., NEUTRALIZATION OF A CLADE-B PRIMARY ISOLATE BY SERA FROM HUMAN-IMMUNODEFICIENCY-VIRUS-UNINFECTED RECIPIENTS OF CANDIDATE AIDS VACCINES, The Journal of infectious diseases, 175(4), 1997, pp. 764-774
EVALUATION OF A LIVE ATTENUATED BOVINE PARAINFLUENZA TYPE-3 VACCINE IN 2 TO 6-MONTH-OLD INFANTS
Authors: KARRON RA MAKHENE M GAY K WILSON MH CLEMENTS ML MURPHY BR
Citation: Ra. Karron et al., EVALUATION OF A LIVE ATTENUATED BOVINE PARAINFLUENZA TYPE-3 VACCINE IN 2 TO 6-MONTH-OLD INFANTS, The Pediatric infectious disease journal, 15(8), 1996, pp. 650-654
IMMUNIZATION WITH ENVELOPE SUBUNIT VACCINE PRODUCTS ELICITS NEUTRALIZING ANTIBODIES AGAINST LABORATORY-ADAPTED BUT NOT PRIMARY ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
Authors: MASCOLA JR SNYDER SW WEISLOW OS BELAY SM BELSHE RB SCHWARTZ DH CLEMENTS ML DOLIN R GRAHAM BS GORSE GJ KEEFER MC MCELRATH MJ WALKER MC WAGNER KF MCNEIL JG MCCUTCHAN FE BURKE DS
Citation: Jr. Mascola et al., IMMUNIZATION WITH ENVELOPE SUBUNIT VACCINE PRODUCTS ELICITS NEUTRALIZING ANTIBODIES AGAINST LABORATORY-ADAPTED BUT NOT PRIMARY ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, The Journal of infectious diseases, 173(2), 1996, pp. 340-348
EFFECTIVE IMMUNIZATION WITH LIVE ATTENUATED INFLUENZA-A VIRUS CAN BE ACHIEVED IN EARLY INFANCY
Authors: CLEMENTS ML MAKHENE MK KARRON RA MURPHY BR STEINHOFF MC SUBBARAO K WILSON MH WRIGHT PF
Citation: Ml. Clements et al., EFFECTIVE IMMUNIZATION WITH LIVE ATTENUATED INFLUENZA-A VIRUS CAN BE ACHIEVED IN EARLY INFANCY, The Journal of infectious diseases, 173(1), 1996, pp. 44-51
SAFETY AND IMMUNOGENICITY OF A CANDIDATE HIV-1 VACCINE IN HEALTHY-ADULTS - RECOMBINANT GLYCOPROTEIN (RGP)-120 - A RANDOMIZED, DOUBLE-BLIND TRIAL
Authors: GRAHAM BS KEEFER MC MCELRATH MJ GORSE GJ SCHWARTZ DH WEINHOLD K MATTHEWS TJ ESTERLITZ JR SINANGIL F FAST PE WRIGHT PF DOLIN R COREY L BELSHE RB CLEMENTS ML BOLOGNESI DP STABLEIN DM CHERNOFF D DULIEGE AM WALKER CM
Citation: Bs. Graham et al., SAFETY AND IMMUNOGENICITY OF A CANDIDATE HIV-1 VACCINE IN HEALTHY-ADULTS - RECOMBINANT GLYCOPROTEIN (RGP)-120 - A RANDOMIZED, DOUBLE-BLIND TRIAL, Annals of internal medicine, 125(4), 1996, pp. 270
MEDICAL ELIGIBILITY, COMPREHENSION OF THE CONSENT PROCESS, AND RETENTION OF INJECTION-DRUG USERS RECRUITED FOR AN HIV VACCINE TRIAL
Authors: HARRISON K VLAHOV D JONES K CHARRON K CLEMENTS ML
Citation: K. Harrison et al., MEDICAL ELIGIBILITY, COMPREHENSION OF THE CONSENT PROCESS, AND RETENTION OF INJECTION-DRUG USERS RECRUITED FOR AN HIV VACCINE TRIAL, Journal of acquired immune deficiency syndromes and human retrovirology, 10(3), 1995, pp. 386-390
SAFETY AND IMMUNOGENICITY OF A COLD-ADAPTED INFLUENZA-A (H1N1) REASSORTANT VIRUS-VACCINE ADMINISTERED TO INFANTS LESS-THAN-6 MONTHS OF AGE
Authors: KARRON RA STEINHOFF MC SUBBARAO EK WILSON MH MACLEOD K CLEMENTS ML FRIES LF MURPHY BR CLEMENTS ML
Citation: Ra. Karron et al., SAFETY AND IMMUNOGENICITY OF A COLD-ADAPTED INFLUENZA-A (H1N1) REASSORTANT VIRUS-VACCINE ADMINISTERED TO INFANTS LESS-THAN-6 MONTHS OF AGE, The Pediatric infectious disease journal, 14(1), 1995, pp. 10-16
STUDIES ON HIV-1 VACCINES BY THE AIDS VACCINE EVALUATION GROUP (AVEG)
Authors: BELSHE RB BOLOGNESI D CLEMENTS ML COREY L FAST P GRAHAM B KEEFER M MESTECKY J MULLIGAN M
Citation: Rb. Belshe et al., STUDIES ON HIV-1 VACCINES BY THE AIDS VACCINE EVALUATION GROUP (AVEG), AIDS research and human retroviruses, 11, 1995, pp. 138-138
PROGRESS TOWARD THE DEVELOPMENT OF A LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE
Authors: MURPHY BR CROWE JE BUI PT ELKINS WR FIRESTONE CY CHANOCK RM LUBECK MD KARRON R CLEMENTS ML WRIGHT PF SIBER GR
Citation: Br. Murphy et al., PROGRESS TOWARD THE DEVELOPMENT OF A LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE, Journal of cellular biochemistry, 1995, pp. 274-274
SCIENTIFIC AND PUBLIC-HEALTH RATIONALE FOR HIV VACCINE EFFICACY TRIALS
Authors: AHOUANTO M ANDERSON R BARBOSA J BELOQUI J BHAMARAPRAVATI N BURKE D DECASTILHO EA CLEMENTS ML COUTINHO R FAST P GIRARD M GNAORE E HAASE A JAFFE H JOHNSTON M KALEEBA N KALLINGS L LEVY JP MBIDDE M MOORE J ABBING ER SCHULTZ A THONGCHAROEN P TRIPATHY S WIGZELL H DULIEGE AM WALKER C OBIJESKI J FRANCIS D BERMAN P MANNHALTER J EXCLER JL DEWILDE M PANICALI D MERSON MH PIOT P ESPARZA J OSMANOV S HEYWARD W MANE P FERRY B SCHOPPER D
Citation: M. Ahouanto et al., SCIENTIFIC AND PUBLIC-HEALTH RATIONALE FOR HIV VACCINE EFFICACY TRIALS, AIDS, 9(3), 1995, pp. 1-4
HIV-1 RECOMBINANT GP160 VACCINE-INDUCED ANTIBODIES IN SERUM AND SALIVA
Authors: GORSE GJ ROGERS JH PERRY JE NEWMAN FK FREY SE PATEL GB BELSHE RB SCHWARTZ DH CLEMENTS ML KEEFER M DOLIN R MCELRATH J COREY L GRAHAM BS WRIGHT PF STABLEIN DM MATTHEWS TJ BOLOGNESI D MESTECKY J WALKER MC FAST PE
Citation: Gj. Gorse et al., HIV-1 RECOMBINANT GP160 VACCINE-INDUCED ANTIBODIES IN SERUM AND SALIVA, Vaccine, 13(2), 1995, pp. 209-214
HUMAN IMMUNE-RESPONSES TO INFLUENZA-VIRUS VACCINES ADMINISTERED BY SYSTEMIC OR MUCOSAL ROUTES
Authors: MOLDOVEANU Z CLEMENTS ML PRINCE SJ MURPHY BR MESTECKY J
Citation: Z. Moldoveanu et al., HUMAN IMMUNE-RESPONSES TO INFLUENZA-VIRUS VACCINES ADMINISTERED BY SYSTEMIC OR MUCOSAL ROUTES, Vaccine, 13(11), 1995, pp. 1006-1012
LIVE ATTENUATED MUTANTS OF RESPIRATORY SYNCYTIAL VIRUS (RSV) - IN-VITRO MARKERS AND REPLICATION IN MICE OR CHIMPANZEES CORRELATE WITH LEVELOF ATTENUATION FOR SERONEGATIVE HUMAN INFANTS
Authors: CROWE JE BUI PT KARRON RA CLEMENTS ML WRIGHT PF CHANOCK RM MURPHY BR
Citation: Je. Crowe et al., LIVE ATTENUATED MUTANTS OF RESPIRATORY SYNCYTIAL VIRUS (RSV) - IN-VITRO MARKERS AND REPLICATION IN MICE OR CHIMPANZEES CORRELATE WITH LEVELOF ATTENUATION FOR SERONEGATIVE HUMAN INFANTS, Pediatric research, 37(4), 1995, pp. 172-172
A LIVE HUMAN PARAINFLUENZA TYPE-3 VIRUS-VACCINE IS ATTENUATED AND IMMUNOGENIC IN HEALTHY INFANTS AND CHILDREN
Authors: KARRON RA WRIGHT PF NEWMAN FK MAKHENE M THOMPSON J SAMORODIN R WILSON MH ANDERSON EL CLEMENTS ML MURPHY BR BELSHE RB
Citation: Ra. Karron et al., A LIVE HUMAN PARAINFLUENZA TYPE-3 VIRUS-VACCINE IS ATTENUATED AND IMMUNOGENIC IN HEALTHY INFANTS AND CHILDREN, The Journal of infectious diseases, 172(6), 1995, pp. 1445-1450
INDUCTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SPECIFIC CYTOLYTIC T-LYMPHOCYTE RESPONSES IN SERONEGATIVE ADULTS BY A NONREPLICATING, HOST-RANGE-RESTRICTED CANARYPOX VECTOR (ALVAC) CARRYING THE HIV-1(MN) ENV GENE
Authors: EGAN MA PAVLAT WA TARTAGLIA J PAOLETTI E WEINHOLD KJ CLEMENTS ML SILICIANO RF
Citation: Ma. Egan et al., INDUCTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SPECIFIC CYTOLYTIC T-LYMPHOCYTE RESPONSES IN SERONEGATIVE ADULTS BY A NONREPLICATING, HOST-RANGE-RESTRICTED CANARYPOX VECTOR (ALVAC) CARRYING THE HIV-1(MN) ENV GENE, The Journal of infectious diseases, 171(6), 1995, pp. 1623-1627
A LIVE ATTENUATED BOVINE PARAINFLUENZA VIRUS TYPE-3 VACCINE IS SAFE, INFECTIOUS, IMMUNOGENIC, AND PHENOTYPICALLY STABLE IN INFANTS AND CHILDREN
Authors: KARRON RA WRIGHT PF HALL SL MAKHENE M THOMPSON J BURNS BA TOLLEFSON S STEINHOFF MC WILSON MH HARRIS DO CLEMENTS ML MURPHY BR
Citation: Ra. Karron et al., A LIVE ATTENUATED BOVINE PARAINFLUENZA VIRUS TYPE-3 VACCINE IS SAFE, INFECTIOUS, IMMUNOGENIC, AND PHENOTYPICALLY STABLE IN INFANTS AND CHILDREN, The Journal of infectious diseases, 171(5), 1995, pp. 1107-1114
EFFECT OF VASCULAR SMOOTH-MUSCLE CELL (SMC) STRETCH ON ALPHA-ADRENOCEPTOR (AR) SUBTYPE GENE-EXPRESSION AND SMC GROWTH
Authors: CLEMENTS ML PING P BANES AJ FABER JE
Citation: Ml. Clements et al., EFFECT OF VASCULAR SMOOTH-MUSCLE CELL (SMC) STRETCH ON ALPHA-ADRENOCEPTOR (AR) SUBTYPE GENE-EXPRESSION AND SMC GROWTH, The FASEB journal, 8(5), 1994, pp. 10001036-10001036
EFFECT OF VASCULAR SMOOTH-MUSCLE CELL (SMC) STRETCH ON ALPHA-ADRENOCEPTOR (AR) SUBTYPE GENE-EXPRESSION AND SMC GROWTH
Authors: CLEMENTS ML PING P BANES AJ FABER JE
Citation: Ml. Clements et al., EFFECT OF VASCULAR SMOOTH-MUSCLE CELL (SMC) STRETCH ON ALPHA-ADRENOCEPTOR (AR) SUBTYPE GENE-EXPRESSION AND SMC GROWTH, The FASEB journal, 8(4), 1994, pp. 10000051-10000051
CYTOTOXIC T-LYMPHOCYTE RESPONSES TO RECOMBINANT CANARYPOX-GP160 MN (ALVAC VCP125, HIV-1 GP160 MN) IN HIV-1 UNINFECTED ADULT VOLUNTEERS
Authors: EGAN MA WEINHOLD K PAOLETTI E TARTAGLIA J CLEMENTS ML PAVLAT W SILICIANO RF
Citation: Ma. Egan et al., CYTOTOXIC T-LYMPHOCYTE RESPONSES TO RECOMBINANT CANARYPOX-GP160 MN (ALVAC VCP125, HIV-1 GP160 MN) IN HIV-1 UNINFECTED ADULT VOLUNTEERS, AIDS research and human retroviruses, 10, 1994, pp. 190000089-190000089
SAFETY PROFILE OF HIV VACCINATION - FIRST 1000 VOLUNTEERS OF AIDS VACCINE EVALUATION GROUP
Authors: KEEFER MC BELSHE R GRAHAM B MCELRATH J CLEMENTS ML SPOSTO R FAST P
Citation: Mc. Keefer et al., SAFETY PROFILE OF HIV VACCINATION - FIRST 1000 VOLUNTEERS OF AIDS VACCINE EVALUATION GROUP, AIDS research and human retroviruses, 10, 1994, pp. 190000139-190000140
EXPANDED SAFETY AND IMMUNOGENICITY TRIAL OF RECOMBINANT GP120 VACCINES VOLUNTEERS (AVEG PROTOCOL-201)
Authors: MCELRATH MJ COREY L CLEMENTS ML BELSHE R KEEFER M GRAHAM B SPOSTO R FAST P
Citation: Mj. Mcelrath et al., EXPANDED SAFETY AND IMMUNOGENICITY TRIAL OF RECOMBINANT GP120 VACCINES VOLUNTEERS (AVEG PROTOCOL-201), AIDS research and human retroviruses, 10, 1994, pp. 190000155-190000155
STUDIES OF HIGH-DOSES OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RECOMBINANT GLYCOPROTEIN-160 CANDIDATE VACCINE IN HIV TYPE-1-SERONEGATIVE HUMANS
Authors: KEEFER MC GRAHAM BS BELSHE RB SCHWARTZ D COREY L BOLOGNESI DP STABLEIN DM MONTEFIORI DC MCELRATH MJ CLEMENTS ML GORSE GJ WRIGHT PF MATTHEWS TJ SMITH GE LAWRENCE D DOLIN R
Citation: Mc. Keefer et al., STUDIES OF HIGH-DOSES OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RECOMBINANT GLYCOPROTEIN-160 CANDIDATE VACCINE IN HIV TYPE-1-SERONEGATIVE HUMANS, AIDS research and human retroviruses, 10(12), 1994, pp. 1713-1723
Risultati: 1-25 | 26-45